1. Build a Strong Employer BrandFirst up, let’s talk about your employer brand. Think of it as your company’s personality and reputation. In Japan’s competitive pharmaceutical and medical device industry, it’s crucial to stand out. You need to showcase your…
BUSINESS
Kissei Takes Over Distribution of Desmopressin Brands from Ferring in Japan
Ferring Pharmaceuticals said on February 25 that it will transfer the Japan distribution rights to its desmopressin brands (nine products), including Minirinmelt, to Kissei Pharmaceutical. Seven of the nine products are currently marketed by Kyowa Kirin and copromoted by Kyowa…
To read the full story
Related Article
- Ferring, Kissei Wind Up Desmopressin Collaboration
January 15, 2025
BUSINESS
- Otsuka Achieves 2-Digit Growth Driven by Core Products
February 17, 2025
- Darzquro Filed for High-Risk Smoldering MM in Japan: J&J
February 17, 2025
- Nxera Founder Tamura to Bow Out from Board
February 17, 2025
- Kerendia Filed for Chronic Heart Failure in Japan: Bayer
February 17, 2025
- Takeda Files Liquid Formulation of IVIg Therapy in Japan
February 17, 2025
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…